CEST in Low-grade Glioma Study

Status Recruiting

Clinical Trial Summary

Low grade gliomas (LGGs) are malignant, infiltrative and incurable brain tumours that typically present in the younger population. This project proposes to use non-contrast metabolic "Saturation Transfer" (ST)-MRI to evaluate LGG tumour progression and aims to predict early changes in LGG. Early identification of LGG patients whose tumours will progress will permit early interventions. ST-MRI does not involve any intravenous injection of contrast and which acquires metabolic information not seen by standard MRI.

Clinical Trial Description

Please see trial details below: ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05996653
Study type	Interventional
Source	Sunnybrook Health Sciences Centre
Contact	Mary Jane Lim-Fat, MD
Phone	416-480-6100
Email	MaryJane.LimFat@sunnybrook.ca
Status	Recruiting
Phase	N/A
Start date	August 12, 2022
Completion date	August 12, 2028

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04734444` - SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue	N/A
Recruiting	`NCT01837862` - A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas	Phase 1/Phase 2
Recruiting	`NCT06104488` - A Study of Avutometinib for People With Solid Tumor Cancers	Phase 1
Completed	`NCT04659421` - Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas	Phase 2
Recruiting	`NCT04174820` - Child's Study of the Impact of PF Lesion on Motor Skills, Language, Cognitive Functioning and Social Cognition
Completed	`NCT02197637` - Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma	Phase 2
Completed	`NCT05373394` - Evaluation of Cognitive and Motor Neurological Disorders in the Short and Long Term After Surgery for the Removal of a Diffuse Low-grade Glioma of the Supplementary Motor Area
Recruiting	`NCT05406700` - Niraparib In Recurrent IDH 1/2 Gliomas	Early Phase 1
Active, not recruiting	`NCT04865315` - A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors
Recruiting	`NCT06159478` - Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)	Phase 2
Recruiting	`NCT06381570` - Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas	Early Phase 1
Terminated	`NCT03763422` - Trial in Low Grade Glioma Patients: Wait or Treat	Phase 3
Completed	`NCT04346472` - Longitudinal MRI Assessment in Patients With Diffuse Low-grade Gliomas
Active, not recruiting	`NCT03948490` - Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas	N/A
Recruiting	`NCT04923126` - SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma	Phase 1/Phase 2
Completed	`NCT00782626` - Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas	Phase 2
Completed	`NCT05873946` - Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery
Not yet recruiting	`NCT05555550` - Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG	Early Phase 1
Withdrawn	`NCT05233215` - GROW (Glioma Specialists Reaching Out With Support) Support	N/A
Completed	`NCT01497860` - Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas	Phase 2